Pertuzumab for HER2 positive metastatic bc

http://www.sciencedaily.com/releases/2014/09/14092...

http://medicalxpress.com/news/2014-09-pertuzumab-m...

http://www.reuters.com/article/2014/09/28/health-c...

http://www.medpagetoday.com/MeetingCoverage/ESMO/4...

"Patients with HER2-positive breast cancer that has spread to other parts of their body live around 16 months longer if treated with a combination of pertuzumab, trastuzumab and chemotherapy compared to those treated with trastuzumab and chemotherapy alone, updated results from the CLEOPATRA study reveal"

Comments

Categories